Data Breach and Delayed Notification Bring Crop of Suits Against Conduent
Cybercriminals are increasingly targeting healthcare organizations due to their vast stores of sensitive information, including patients' financial data, medical records, and personal details. These data command high prices on the dark web.
Legal Technology and Litigation Insights
The Am Law 100 ranks the 100 largest law firms in the United States and offers dynamic data exploration on law firms, companies, lawyers, and industry trends. It provides real-time alerts on new state and federal litigation, unlimited complaint access, expert case summaries, and AI-enhanced trend detection.
Pfizer’s Legal Action Against Metsera and Novo Nordisk
Pfizer has filed for a temporary restraining order to prevent Metsera from breaching their contract and entering into a deal with Novo Nordisk.
"A reasonable juror could find that the defendants’ 'blaming supply,' making uncompetitively high bids and falsely citing production costs for increased prices were aimed at concealing their alleged conspiracy," the court ruled.
Pfizer claims that Novo Nordisk is trying to "catch and kill" Metsera, which Pfizer was acquiring, to suppress competition against Novo Nordisk's obesity treatments, Ozempic and Wegovy.
Author's summary: Healthcare data breaches attract lawsuits due to the sensitivity and value of information, while competitive disputes in the pharmaceutical industry lead to intense legal battles involving acquisition contracts and alleged conspiracies.